Dr. Jean Jacques Kiladjian ASH 2018 Research Studies
Ropeg 3 yr follow-up vs HU, MPNs in patients under age of 25 at diagnosis, Targeting JAK2 mutation with IFN and Arsenic, see interview here -...
Ropeg 3 yr follow-up vs HU, MPNs in patients under age of 25 at diagnosis, Targ...